CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleMarket cap is $239.94M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 13.93: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
239.94MUSDvs all stocks (USD)
Revenue (TTM)
14.41MUSDvs all stocks (USD)
Profit Margin
-236.05%Beta
1.36xvs all stocks
52-Week Change
-31.45%vs all stocks
Market Capitalization
239.94MUSDvs all stocks (USD)
Enterprise Value
199.17MUSDvs all stocks (USD)
Forward P/E
9.91xPrice to Sales (TTM)
16.65xPrice to Book (MRQ)
3.79xEnterprise to Revenue
13.82xEnterprise to EBITDA
-5.23xGross Margin
42.55%Profit Margin
-236.05%Operating Margin
-128.56%Return on Assets (TTM)
-40.22%Return on Equity (TTM)
-73.62%Revenue (TTM)
14.41MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.3440USDUpdated Sep 26, 2026Quarterly Revenue Growth
409.00%Gross Profit (TTM)
1.94MUSDvs all stocks (USD)
EBITDA (TTM)
-38.09MUSDvs all stocks (USD)
Net Income (TTM)
-34.03MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
408.97%Operating Cash Flow (TTM)
-35.00MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-26.92MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 26, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
-1.55MUSDFY2025 · Dec 31, 2025Revenue
7.90MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
6.81MUSDFY2025 · Dec 31, 2025Gross Profit
1.09MUSDFY2025 · Dec 31, 2025Operating Income
-36.46MUSDvs all stocks (USD)
Pre-tax Income
-36.06MUSDFY2025 · Dec 31, 2025Net Income
-38.48MUSDFY2025 · Dec 31, 2025EBIT
-35.87MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-35.04MUSDFY2025 · Dec 31, 2025Research & Development
9.94MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
26.16MUSDFY2025 · Dec 31, 2025Other Operating Expenses
951.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
185.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.03USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.03USDFY2025 · Dec 31, 2025Basic Shares Outstanding
36.96MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
36.96MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-38.48MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
749.00KUSDFY2025 · Dec 31, 2025Operating Cash Flow
-22.43MUSDFY2025 · Dec 31, 2025Free Cash Flow
-22.88MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
13.53MUSDFY2025 · Dec 31, 2025Interest Paid
29.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-38.48MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
815.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
20.36MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-5.03MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
3.01MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.10MUSDFY2025 · Dec 31, 2025Capital Expenditures
-452.00KUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-637.00KUSDFY2025 · Dec 31, 2025Net Acquisitions
-47.00KUSDFY2025 · Dec 31, 2025Purchase of Investments
-55.64MUSDFY2025 · Dec 31, 2025Other Investing Activity
-241.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-56.38MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.55MUSDFY2025 · Dec 31, 2025Other Financing Charges
-1.85MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
62.32MUSDFY2025 · Dec 31, 2025Shares Outstanding
44.00MSharesUpdated Sep 26, 2026Float Shares
34.47MSharesUpdated Sep 26, 2026Shares Short
4.63MSharesUpdated Sep 26, 2026Short Ratio
9.24daysvs all stocks
Short % of Shares Outstanding
10.79%vs all stocks
% Held by Insiders
14.70%vs all stocks
% Held by Institutions
44.34%vs all stocks
Total Cash (MRQ)
43.40MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
0.9860USDUpdated Sep 26, 2026Total Debt (MRQ)
4.55MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0724xCurrent Ratio (MRQ)
7.52xBook Value per Share (MRQ)
1.44USDUpdated Sep 26, 2026Total Assets
85.16MUSDvs all stocks (USD)
Total Current Assets
79.41MUSDFY2025 · Dec 31, 2025Total Liabilities
8.74MUSDFY2025 · Dec 31, 2025Total Non-current Assets
5.75MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.79MUSDFY2025 · Dec 31, 2025Total Current Liabilities
6.95MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
13.53MUSDFY2025 · Dec 31, 2025Other Short-term Investments
56.03MUSDFY2025 · Dec 31, 2025Accounts Receivable
3.03MUSDFY2025 · Dec 31, 2025Inventory
3.89MUSDFY2025 · Dec 31, 2025Accounts Payable
3.35MUSDFY2025 · Dec 31, 2025Short-term Debt
828.00KUSDFY2025 · Dec 31, 2025Other Current Liabilities
576.00KUSDFY2025 · Dec 31, 2025Long-term Debt
1.79MUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-138.19MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
76.42MUSDvs all stocks (USD)
52-Week Low
4.97USDUpdated Sep 26, 202652-Week High
8.72USDUpdated Sep 26, 202652-Week Change
-31.45%vs all stocks
Beta
1.36xvs all stocks
50-Day MA
6.16USDUpdated Sep 26, 2026200-Day MA
6.40USDUpdated Sep 26, 2026Avg 10-Day Volume
353.41KSharesUpdated Sep 26, 2026Avg 30-Day Volume
502.32KSharesUpdated Sep 26, 2026Diluted EPS (TTM)
-0.8200USDUpdated Sep 26, 2026Other Income / Expense
-16.00KUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 4.09Receivables vs revenue divergence: 8.08
High gross margins eroded by operating costsNotable
Gross Margin: 0.43Profit Margin: -2.36
Financial Health
Altman Z-Score 13.93: safe zoneNotable
Altman Z-Score: 13.93
High structural barrier to entryNotable
Barrier to Entry: 3.10
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $239.94M, lower than 95% of all stocks globallySignificant
Market cap (USD): 239,944,245Global P5: 275,556,405.438
Revenue is $14.42M, lower than 95% of all stocks globallySignificant
Revenue (USD): 14,415,000Global P5: 33,357,653.812
Companies that share the same coordination system — how they create, deliver, or capture value.
Verve Group SE
Tier 1InterfaceRecurring-Revenue Lock-InAttentionFlow
PCA Corp.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Synagistics Limited
Tier 1InterfaceRecurring-Revenue Lock-InSenseMakingProduction
Cafe24 Corp.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Safie Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Dear U Co., Ltd.
Tier 1InterfaceRecurring-Revenue Lock-InAttentionFlow
Dotdigital Group plc
Tier 1InterfaceRecurring-Revenue Lock-InProductionSenseMaking
Commerce.com, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Smartrent Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Tasuki Holdings Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Geron Corporation
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Hinova Pharmaceuticals Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Hyliion Holdings Corp.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC